Form D Explorer

Form D — KAZIA THERAPEUTICS LTD

0001470831-25-000129 · filed 2025-08-14

Offering

Industry: Biotechnology
Exemptions: 06b
Total offering: $2,050,013
Total sold: $2,050,013
Minimum investment: $0
Investors: —
Sales commission: —
Finders' fees: —

Issuer

Name: KAZIA THERAPEUTICS LTD
CIK: 1075880
Entity: Corporation
Jurisdiction: AUSTRALIA
Year incorporated: —
Address: THREE INTERNATIONAL TOWERS LEVEL 24,
SYDNEY NSW, C3 2000
Phone: 01161298780088

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

John Friend · Executive Officer

Sydney, C3 Find on LinkedIn ↗
Bryce Carmine · Director

Sydney, C3 Find on LinkedIn ↗
Steven Coffey · Director

Sydney, C3 Find on LinkedIn ↗
Ebru Davidson · Director

Sydney, C3 Find on LinkedIn ↗
Robert Apple · Director

Sydney, C3 Find on LinkedIn ↗
Jeffrey Bonacorda · Executive Officer

Sydney, C3 Find on LinkedIn ↗
Elissa Hansen · Executive Officer

Sydney, C3 Find on LinkedIn ↗

View original on SEC EDGAR.